The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Hepatic microvascular regulatory mechanisms. IV. Effect of lodoxamide tromethamine and arterenol-HCl on vascular responses evoked by compound 48/80.

Changes in the hepatic microvasculature and systemic arterial blood pressure were measured in anesthetized Sprague-Dawley rats receiving an i.v. infusion or topical application of compound 48/80, lodoxamide, or arterenol. Histochemical determination of the number of Falck-Hillarp positive (serotonin containing) mast cells also was performed on sections of liver at the light microscopic level. The infusion of arterenol (0.1 mg/kg) or Ringer's solution (control) provoked a vasopressor response within 25 sec in rats rendered hypotensive 5 min previously with compound 48/80. The duration of this response was brief with arterial pressure returning to the pre-injection (hypotensive) state within 3 min following arterenol or Ringer's administration. The injection of lodoxamide (a purported inhibitor of histamine release) inhibited compound 48/80-induced hypotension at all doses except 1 mg/kg. In vivo microscopy revealed that topical administration (0.1 microgram) significantly antagonized the microvascular responses elicited by compound 48/80. However, higher doses of lodoxamide (1.0-10 micrograms) when applied topically were found to be vasoactive. Given these results and the histochemical demonstration of an inhibition of compound 48/80-induced release of serotonin, it is suggested that: lodoxamide antagonizes the action of compound 48/80 by blocking the release of mast cell constituents, and neither compound 48/80 nor the released constituents appear to modify vascular responsiveness to arterenol or hypervolemia following the initiation of hypotension.[1]


WikiGenes - Universities